This company is no longer active
The company may no longer be operating, as it may be out of business. Find out why through their latest events.
このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Zosano Pharma 過去の業績
過去 基準チェック /06
主要情報
-5.0%
収益成長率
75.3%
EPS成長率
| Medical Equipment 業界の成長 | 8.9% |
| 収益成長率 | 86.7% |
| 株主資本利益率 | -392.7% |
| ネット・マージン | -8,375.1% |
| 前回の決算情報 | 31 Mar 2022 |
最近の業績更新
Recent updates
Can Zosano Pharma (NASDAQ:ZSAN) Afford To Invest In Growth?
Nov 02
Is Zosano Pharma (NASDAQ:ZSAN) Weighed On By Its Debt Load?
Jun 29Data supports long-term benefit of Zosano's migraine candidate; shares surge 23%
May 26Zosano Pharma: Early PK+Safety Study In Q3 2021 May Breathe New Life Into This Biotech
Apr 30Zosano shares rise on migraine treatment NDA resubmission update
Apr 26Auditors Have Doubts About Zosano Pharma (NASDAQ:ZSAN)
Mar 15Zosano Pharma up 21% following FDA feedback on Qtrypta application; presents Qtrypta data in migraine
Feb 01Zosano Pharma requests FDA meeting for its Qtrypta application
Jan 04Zosano Pharma EPS misses by $0.01
Nov 13収支内訳
収支内訳
Zosano Pharma の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 31 Mar 22 | 1 | -55 | 11 | 0 |
| 31 Dec 21 | 1 | -30 | 11 | 0 |
| 30 Sep 21 | 1 | -31 | 11 | 0 |
| 30 Jun 21 | 1 | -31 | 11 | 0 |
| 31 Mar 21 | 0 | -33 | 11 | 0 |
| 31 Dec 20 | 0 | -33 | 11 | 0 |
| 30 Sep 20 | 0 | -34 | 12 | 0 |
| 30 Jun 20 | 0 | -35 | 12 | 0 |
| 31 Mar 20 | 0 | -37 | 12 | 0 |
| 31 Dec 19 | 0 | -38 | 12 | 0 |
| 30 Sep 19 | 0 | -39 | 11 | 0 |
| 30 Jun 19 | 0 | -37 | 10 | 0 |
| 31 Mar 19 | 0 | -37 | 10 | 0 |
| 31 Dec 18 | 0 | -35 | 9 | 0 |
| 30 Sep 18 | 0 | -33 | 9 | 0 |
| 30 Jun 18 | 0 | -32 | 8 | 0 |
| 31 Mar 18 | 0 | -30 | 8 | 0 |
| 31 Dec 17 | 0 | -29 | 8 | 0 |
| 30 Sep 17 | 0 | -29 | 8 | 0 |
| 30 Jun 17 | 0 | -29 | 8 | 0 |
| 31 Mar 17 | 0 | -29 | 8 | 0 |
| 31 Dec 16 | 0 | -30 | 8 | 0 |
| 30 Sep 16 | 0 | -30 | 8 | 0 |
| 30 Jun 16 | 0 | -31 | 7 | 0 |
| 31 Mar 16 | 0 | -32 | 7 | 0 |
| 31 Dec 15 | 0 | -28 | 6 | 0 |
質の高い収益: ZSAN.Q is currently unprofitable.
利益率の向上: ZSAN.Q is currently unprofitable.
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: ZSAN.Q is unprofitable, and losses have increased over the past 5 years at a rate of 5% per year.
成長の加速: Unable to compare ZSAN.Q's earnings growth over the past year to its 5-year average as it is currently unprofitable
収益対業界: ZSAN.Q is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-10%).
株主資本利益率
高いROE: ZSAN.Q has a negative Return on Equity (-392.74%), as it is currently unprofitable.